| Literature DB >> 34136608 |
John V Horberg1,2, J Ross Bailey1, Kathleen Kay1, D Gordon Allan1,2.
Abstract
BACKGROUND: There is no consensus on how to best address acetabular insufficiency. Several described techniques have a high rate of loosening and most rely on fixation to intact innominate bones. They also require extensive exposure and expensive implants. We present a novel technique for acetabular insufficiency management including discontinuity and a series with mean 6.5-year follow-up.Entities:
Keywords: Acetabular fracture; Pelvic discontinuity; Protrusio; Revision hip arthroplasty; Staged hip arthroplasty
Year: 2021 PMID: 34136608 PMCID: PMC8180963 DOI: 10.1016/j.artd.2021.04.014
Source DB: PubMed Journal: Arthroplast Today ISSN: 2352-3441
Patient demographic information and timeline associated with care.
| Patient | Hip | Approach | Time between stages | Total follow up |
|---|---|---|---|---|
| 68-y/o Female | Native | Posterior | 5.21 mo | 71 mo |
| 82-y/o Male | Native | Lateral | 4.25 mo | 88 mo |
| 72-y/o Female | Prosthetic | Lateral | 6.53 mo | 129 mo |
| 82-y/o Female | Prosthetic | Posterior | 4.28 mo | 77 mo |
| 78-y/o Male | Prosthetic | Lateral | 6.28 mo | 67 mo |
| 83-y/o Female | Native | Lateral | 9.14 mo | 65 mo |
| 64-y/o Female | Prosthetic | Posterior | 4.67 mo | 67 mo |
| 59-y/o Male | Prosthetic | Posterior | 5.80 mo | 102 mo |
| 61-y/o Female | Native | Lateral | 3.85 mo | 62 mo |
Second stage performed after radiographic evidence of defect healing noted.
The final row denotes averages.
Figure 1A 68-y/o female presented 6 months after nondisplaced native acetabular fracture which failed conservative management and went on to pelvic discontinuity (a). Planned reduction and fixation before arthroplasty failed due to callous making reduction impossible. Acetabulum was prepared in situ with femoral head autograft (b), and the procedure was staged (c).
Figure 2Patient underwent conversion from hemiarthroplasty to total hip arthroplasty at an outlying facility. Acetabular fracture with protrusion noted at 6-week follow-up with no reported history of fall or trauma (a). Referred to tertiary center and staged procedure with allograft performed electively (b-c).
All patients were managed with conventional porous coated acetabular shells (Continuum, Zimmer) and conventional bearings.
| Components used | |||
|---|---|---|---|
| Patient | Shell | Head | Femur |
| 68-y/o Female | 52 mm Multihole | 32 mm CoCr | Metaphyseal tapered wedge |
| 82-y/o Male | 66 mm Multihole | 36 mm CoCr | Diaphyseal fully bead coated |
| 72-y/o Female | 58 mm Multihole | 36 mm CoCr | Metaphyseal/diaphyseal modular |
| 82-y/o Female | 56 mm Multihole | 36 mm CoCr | Diaphyseal fully bead coated |
| 78-y/o Male | 62 mm 3-Hole | 36 mm CoCr | Diaphyseal fully bead coated |
| 83-y/o Female | 52 mm 3-Hole | 32 mm CoCr | Metaphyseal tapered wedge |
| 64-y/o Female | 58 mm Multihole | 36 mm Ceramic | Diaphyseal fully bead coated |
| 59-y/o Male | 60 mm 3-Hole | 36 mm Ceramic | Diaphyseal fully bead coated |
| 61-y/o Female | 64 mm 3-Hole | 36 mm CoCr | Metaphyseal tapered wedge |
A mixture of tapered wedge (Avenir, Zimmer) fully coated diaphyseal (Versys, Zimmer) and modular (AcuMatch, ExacTech) femoral components was used.
Merle d’Aubinge scores were available at initial preoperative visit and at yearly follow-up.
| Patient | Preoperatively | Final follow-up | |||
|---|---|---|---|---|---|
| Merle d’Aubinge | VAS | Merle d’Aubinge | VAS | Implants | |
| 68-y/o Female | 4 | 8 | 16 | 2 | Intact |
| 82-y/o Male | 4 | 9 | 14 | 1 | Intact |
| 72-y/o Female | 6 | 8 | 14 | 1 | Intact |
| 82-y/o Female | 4 | 8 | 15 | 0 | Intact |
| 78-y/o Male | 7 | 5 | 16 | 0 | Intact |
| 83-y/o Female | 7 | 7 | 14 | 2 | Intact |
| 64-y/o Female | 7 | 6 | 18 | 0 | Intact |
| 59-y/o Male | 4 | 8 | 17 | 0 | Intact |
| 61-y/o Female | 8 | 6 | 14 | 2 | Intact |
Visual analog scale (VAS) scores recorded at every visit. All implants functioning and all patients ambulating at the terminal follow-up.
The final row denotes averages.
Single superficial surgical site infection managed with cephalexin.
| Complications | ||||
|---|---|---|---|---|
| Complications | Stage I | Stage II | Final follow-up | Total |
| Stitch/Wound | 0 | 1 | 0 | 1 |
| Deep infection | 0 | 0 | 0 | 0 |
| Hematoma | 0 | 0 | 0 | 0 |
| Greater trochanter fracture | 0 | 2 | 0 | 2 |
| Calcar fracture | 0 | 1 | 0 | 1 |
| Acetabular fracture | N/A | 0 | 0 | 0 |
| Failure of fixation | 0 | 0 | 0 | 0 |
| Dislocation | N/A | 0 | 0 | 0 |
| Heterotopic ossification | 0 | 1 | 0 | 1 |
| Leg length inequality | N/A | 0 | 0 | 0 |
| Thromboembolic | 0 | 0 | 0 | 0 |
| Cardiac events | 0 | 0 | 1∗ | 1∗ |
| Pulmonary complications | 0 | 0 | 0 | 0 |
Both greater trochanter fractures remain nondisplaced at the terminal follow-up. One patient developed Brooker stage 1 heterotopic ossification which required no treatment. ∗ [21] A final patient died 7 years after stage 2 of unrelated cardiac event.